Amrutanjan Health Care
516.90
+6.25(+1.22%)
Market Cap₹1,494.39 Cr
PE Ratio25.87
IndustryHealthcare
Company Performance:
1D+1.22%
1M-11.05%
6M-27.63%
1Y-19.92%
5Y-7.25%
View Company Insightsright
More news about Amrutanjan Health Care
10Nov 25
Amrutanjan Health Care Reports Robust Q2 Performance with 18.4% Profit Growth
Amrutanjan Health Care Limited announced robust Q2 FY2025-26 results. Net profit increased by 18.4% to ₹139.60 crore, while revenue grew 7.1% to ₹1,177.00 crore. EBITDA rose 21.5% to ₹165.20 crore, with EBITDA margin expanding by 166 bps to 14.04%. The company declared a first interim dividend of ₹1 per share, with November 18, 2025, set as the record date.
 no imag found
12Aug 25
Amrutanjan Health Care Reports 80% Profit Surge, Sets AGM Date
Amrutanjan Health Care Limited announced Q1 FY2026 results with an 80% increase in profit after tax to ₹831.12 lakhs. Revenue from operations rose 12.3% to ₹9,404.57 lakhs. EPS improved to ₹2.87. OTC Products remained the largest revenue contributor. The company scheduled its 88th AGM for September 23, 2025, set September 16 as the record date, and appointed M/s. SPNP & Associates as Secretarial Auditor for five years.
 no imag found
15May 25
Amrutanjan Health Care Reports Strong Q4 Results, Announces Dividend
Amrutanjan Health Care's Q4 financial results show significant growth. Revenue increased by 6.30% to ₹1.35 billion, while net profit rose by 11.13% to ₹151.80 million. EBITDA improved to ₹177.00 million with a margin of 13.07%. The company also announced a final dividend of ₹2.60 per equity share, reflecting confidence in its financial position and commitment to shareholder value.
 no imag found
Amrutanjan Health Care
516.90
+6.25
(+1.22%)
1 Year Returns:-19.92%
Industry Peers
Sun Pharmaceutical
1,694.60
(+0.06%)
Divis Laboratories
5,821.00
(-0.61%)
Torrent Pharmaceuticals
4,011.60
(+0.61%)
Lupin
2,279.90
(+0.24%)
Dr Reddys Laboratories
1,217.80
(+0.04%)
Cipla
1,200.90
(+0.71%)
Zydus Life Science
866.30
(+0.24%)
Mankind Pharma
2,017.70
(+0.96%)
Aurobindo Pharma
1,340.40
(+0.50%)
Alkem Laboratories
5,236.50
(-0.41%)